Vimarsana
Biggest News Aggregation in the World

Page 19 - Oaktree Acquisition News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oaktree Acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oaktree Acquisition Today - Breaking & Trending Today

Alvotech Holdings S.A.: Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company - Vimarsana News

Alvotech Holdings S.A.: Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company

Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets. Biosimilars are therapeutic equivalents to

Hims & Hers strikes a deal with The Vitamin Shoppe to sell hair care products - Vimarsana News

Hims & Hers strikes a deal with The Vitamin Shoppe to sell hair care products

Retail industry news, voices and jobs. Optimized for your mobile phone.

D2C virtual care company Ro strengthens reproductive offerings with Modern Fertility acquisition - Vimarsana News

D2C virtual care company Ro strengthens reproductive offerings with Modern Fertility acquisition

Photo courtesy of Ro Ro, a direct-to-consumer virtual care company, is strengthening its foothold in women's health with the acquisition of reproductive health company Modern Fertility for an undisclosed sum. As part of the deal, Modern Fertility's offerings will be offered via Ro's primary care platform. Like Ro, Modern Fertility built up a direct-to-consumer virtual health business. However, Modern Fertility offers users personalized at-home fertility tests or one they can take in the lab. The original test is a hormone test that a clinician is able to review and communicate the results wit...

Hims & Hers Health, Inc. Reports First Quarter 2021 Financial Results - Vimarsana News

Hims & Hers Health, Inc. Reports First Quarter 2021 Financial Results

 |  0  Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the first quarter ending March 31, 2021. “Building on our momentum from last year, Hims & Hers kicked off 2021 with a very strong first quarter, delivering robust revenue growth of 74%, gross profit growth of 95%, and ending the quarter with 391,000 subscriptions on our platform, up nearly 80% year-over-year," said Andrew Dudu...

D2C virtual health company Hims & Hers beats its Q4 expectations - Vimarsana News

D2C virtual health company Hims & Hers beats its Q4 expectations

Photo: IronHeart/Getty Images Consumer telehealth and wellness brand Hims & Hers came out on top of its projections for the first quarter of 2021, according to its financial results report released today. In its report from Q4 2020, Hims & Hers estimated its revenue to total between $48 million and $50 million, while adjusted EBITDA was expected to land within -$9.5 million and -$11.5 million. “Building on our momentum from last year, Hims & Hers kicked off 2021 with a very strong first quarter, delivering robust revenue growth of 74%, gross profit growth of 95%, and ending the quarter wi...